|
REXXOLIDE
|
100 mg/ml
|
EU/2/20/263/003
|
Dechra Regulatory B.V., Nīderlande
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eurovet Animal Health B.V., Nīderlande
|
| Date of authorisation/renewal: |
03-Dec-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/263/003 |
100 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
|
|
NEXGARD SPECTRA
|
-
|
EU/2/14/177/003
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Milbemycin oxime,Afoxolaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
15-Feb-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/14/177/003 |
|
1 |
PVH/Aclar/Al blisteris, 6 tablete |
-
|
|
|
HorStem
|
-
|
EU/2/18/226/001
|
EquiCord-YMAS , Spānija
|
QM09AX
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Equine umbilical cord mesenchymal stem cells
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
EquiCord-YMAS , Spānija
|
| Date of authorisation/renewal: |
19-Jun-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/226/001 |
|
1 |
Flakons, 1 ml |
-
|
|
|
Syvazul BTV
|
-
|
EU/2/18/231/009
|
Laboratorios SYVA S.A.U, Spānija
|
QI04AA02
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated bluetongue virus, serotype 1, strain BTV-1/ALG2006/01 E1, Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
LABORATORIOS SYVA, S.A.U. , Spānija
|
| Date of authorisation/renewal: |
09-Jan-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/231/009 |
|
1 |
Polipropilēna flakons, 80 ml |
-
|
|
|
Fluralaner Intervet
|
45 mg
|
EU/2/25/346/002
|
Intervet International B.V., Nīderlande
|
QP53BE02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
27-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/346/002 |
|
1 |
Blisteris, 2 tablete |
-
|
|
|
Daxocox
|
45 mg
|
EU/2/21/270/019
|
Ecuphar NV, Beļģija
|
QM01AH95
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Enflicoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
20-Apr-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/270/019 |
45 mg |
24 |
Blisteris, 24 tablete |
-
|
|
|
Porcilis ColiClos
|
-
|
EU/2/12/141/007
|
Intervet International B.V., Nīderlande
|
QI09AB08
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
F4ab (K88ab) fimbrial adhesin,F5 (K99) fimbrial adhesin,F4ac (K88ac) fimbrial adhesin,Echerichia coli LT toxoid,F6 fimbrial adhesin of E. coli,Toxoid Clostridium perfringens, type C
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
14-Jun-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/141/007 |
50 deva |
1 |
Stikla pudelīte, 50 deva |
-
|
|
|
Meloxidolor
|
40 mg/ml
|
EU/2/13/148/006
|
Le Vet Beheer B.V., Nīderlande
|
QM01AC06
|
cattle; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Produlab Pharma b.v., Nīderlande
|
| Date of authorisation/renewal: |
20-Apr-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/148/006 |
40 mg/ml |
1 |
Stikla flakons, 50 ml |
-
|
|
|
Bravecto
|
150 mg/ml
|
EU/2/13/158/033
|
Intervet International B.V., Nīderlande
|
QP53BE02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
powder and solvent for suspension for injection
|
| International name (active substance): |
Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet UK Ltd, Lielbritānija
|
| Date of authorisation/renewal: |
11-Feb-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/158/033 |
|
2 |
I tipa stikla flakons, 2,51 g |
-
|
|
|
Ceperolon
|
40 mg
|
EU/2/24/321/005
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QC03DA01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Spironolactone
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
12-Sep-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/321/005 |
40 mg |
1 |
Al/OPA/Al/PVH blisteris, 10 tablete |
-
|
|
|
Metacam
|
20 mg/ml
|
EU/2/97/004/015
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AC06
|
cattle; pigs; horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Labiana Life Sciences S.A., Spānija
|
| Date of authorisation/renewal: |
06-Dec-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/97/004/015 |
20 mg/ml |
12 |
Stikla flakons, 100 ml |
-
|
|
|
Loxitab
|
2.5 mg
|
EU/2/23/301/005
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
19-Oct-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/301/005 |
|
1 |
PVH/PE/PVDH-Al blisteris, 10 tablete |
-
|
|
|
Credelio
|
12 mg
|
EU/2/17/206/016
|
Elanco GmbH, Vācija
|
QP53BE04
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
26-Apr-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/206/016 |
12 mg |
1 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Emevet
|
-
|
EU/2/25/343/009
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QA04AD90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Maropitant
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
02-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/343/009 |
|
1 |
Blisteris, 10 tablete |
-
|
|
|
Novem
|
40 mg/ml
|
EU/2/04/042/017
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AC06
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Labiana Life Sciences S.A., Spānija
|
| Date of authorisation/renewal: |
02-Mar-2004
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/04/042/017 |
40 mg/ml |
12 |
Stikla flakons, 50 ml |
-
|
|
|
EVANT
|
-
|
EU/2/18/233/001
|
Laboratorios Hipra S.A., Spānija
|
QI01AN01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension and solvent for oral spray
|
| International name (active substance): |
Eimeria acervulina, strain 003, Eimeria maxima, strain 013, Eimeria mitis, strain 006, Eimeria praecox, strain 007, Eimeria tenella, strain 004
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
05-Feb-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/233/001 |
|
1 |
Stikla flakons un flakons, 1000 deva |
-
|
|
|
FRONTPRO
|
68 mg
|
EU/2/19/240/010
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs >10–25 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/010 |
68 mg |
1 |
PVH/Aclar/Al blisteris, 3 tablete |
-
|
|
|
Zeleris
|
-
|
EU/2/17/210/002
|
Ceva Sante Animale,, Francija
|
QJ01BA99
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam,Florfenicol
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale,, Francija
|
| Date of authorisation/renewal: |
05-May-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/210/002 |
|
1 |
Plastmasas flakons, 100 ml |
-
|
|
|
Coxatab
|
100 mg
|
EU/2/22/286/013
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
12-Aug-2022
|
| Marketing authorisation valid until: |
11-Aug-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/22/286/013 |
100 mg/tabl. |
1 |
alumīnija/PVC/PE/PVDC blisteris, 10 tablete |
-
|
|
|
Cimalgex
|
8 mg
|
EU/2/10/119/004
|
Vetoquinol S.A., Francija
|
QM01AH93
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Cimicoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
07-Jan-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/119/004 |
8 mg |
1 |
Plastmasas pudele, 45 tablete |
-
|
|